Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
: Hematopoietic Stem Cell/Bone Marrow Transplantation, Solid Organ Transplantation and Histocompatibility Testing and obtain/maintain their California Clinical Histocompatibility Scientist or Director's license
-
prior research experience in one or more of the following areas: metabolism, single-cell transcriptome, 3D tissue or animal models, biomaterials, immunology, and stem cell biology. • Demonstrated
-
of these conditions and find better treatment options for patients with movement disorders. Our researchers are involved in preclinical and clinical research studying possible therapeutics including stem cell therapy
-
LSRP that has an interest in the basic science of stem cells, cardiovascular diseases and drug discovery. The project builds on recent initiatives at the Stanford University Cardiovascular Institute
-
on studying Cancer Biology and Stem Cell Biology in the laboratory of Dr. Lu Le , Professor and Chair of the Department of Dermatology. Dr. Le's lab investigates how genetic and microenvironmental factors
-
proteins in patient-derived cell models and will use induced pluripotent stem cells (iPSCs) from patients with HD to study the role of DDR proteins, in repeat expansion and contraction events. You will use
-
for utilizing human induced pluripotent stem cell-derived models and animal models to study molecular mechanisms of arrhythmias, the effects of current treatments and identify new therapeutic targets. This person
-
; and Knowledge in cell biology, biological diversity or ecology Instructions to Applicants: For full consideration, applicants must apply for Term Professor Biology Open-Rank at https://jobs.gmu.edu
-
complications associated with solid organ transplant or stem cell transplantation or treatment of underlying hematologic or solid tumor malignancies. The Division is a robust group comprised of 30ID physicians
-
immunotherapy modeling is highly desirable, candidates with the following experience will also be considered: stem cell-derived organoid models (specifically brain, lung, or tumor organoids), lab-on-chip